molecular continuity in the processes of the elicitation of lesion formation and therefore the processes that govern the establishment and maintenance of skin homeostasis.
Our objective was to identify conserved gene expression patterns among multiple prevalent inflammatory skin diseases and define a common molecular signature of disrupted skin homeostasis. To this end, we mined publicly available gene expression data in the NCBI Gene Expression Omnibus (GEO) [12] and developed a novel algorithm that identified genes displaying consistent dysregulation in comparisons of lesional skin to normal healthy skin. We termed the strongest, most coordinately regulated genes the "unhealthy skin signature" (USS). Utilizing a pattern-matching algorithm (Connectivity Map; CMap), [13] we found very strong positive linkages of the USS with diverse diseases, ranging from inflammatory diseases of the skin to delayed-type hypersensitivity reactions and various types of cancer. Notably, many genes in the USS had no prior published associations with skin, and gene network analysis showed that these genes are linked to a variety of cellular processes and non-skin conditions/diseases that are inflammatory in nature. This suggests highly conserved patterns of dysregulation of tissue homeostasis that manifest in many different types of disease. Less severe disruptions of skin homeostasis including mechanical stratum corneum damage and mild surfactant disruption of both healthy skin and that of patients prone to seasonal dry skin also converge on the USS. We also show that a therapeutic intervention reverses the pattern of the USS. Finally, using CMap analysis, we show that the USS can be a useful approach to identify new therapeutics to treat skin barrier dysfunction and inflammation.
| ME THODS

| Identifying consistently regulated genes across skin diseases
The algorithm to derive the USS employed gene expression data sets from five skin diseases. The SD data set was our own, [8] while acne, AD, eczema and psoriasis data sets were obtained from GEO [12] with accession numbers of GSE6475, [4] GSE5667, [5] GSE6012 [6] and GSE13355, [7] respectively. Each gene expression profile was normalized using robust multi-array average (RMA). [14] For each disease, lesional biopsy data were compared to healthy skin using a t test. One-tailed t test P-value was computed for each probe and was used to calculate a log-odds ratio. The log-odds ratio was then transformed using a soft threshold function, and the resulting values across all five skin diseases were used to compute a consistency value using a t-statistic-like formula. Probes were then ranked based on the computed consistency value. The top ranked probes represent the most consistently upregulated, and the bottom ranked probes represent the most consistently downregulated. For this study, the top 200 up-and top 200 downregulated probes were used for cross-study analyses. A detailed procedure is provided in Supporting Information (Data S1).
| Constructing CMap database for querying diseases and the perturbagen database
The method for preparing profiles for CMap querying and the pattern-matching algorithm are based on Lamb et al [13] and are detailed in Supporting Information (Data S2). For each condition or perturbagen, an up-score was calculated to reflect the match between the upregulated genes of the query signature (the USS) and the condition or perturbagen, and the same was carried out for the downregulated probes. Scores for each gene list in the query signature range from −1 to +1 (down and up); the combination represents the strength of the overall match between the query signature and the instance. The combination of the up-score and down-score is used to calculate an overall connectivity score for each instance; perfect matches range from −2 to +2.
| Assessing the significance of CMap linkage scores
Random signatures of the same size as the USS (200 up and 200 down) were scored against a ranked list of the same length as the disease database. For 10 million random signatures, the maximum score obtained is 0.31. A score of 0.14 has a significance of 0.05. A cut-off score of 0.4 used in the study is greater than 0.31 and should yield a P-value much lower than 10
. This should remain highly significant after multitest correction for the number of studies we included.
| Gene ontology (GO) theme analysis of USS and interaction networks
The top 200 up-and downregulated non-redundant genes from the USS (by combined consistency score) were entered into ToppCluster. [15, 16] Enrichment for associated GO biological processes (BP) was assessed using an FDR-corrected P-value threshold <.01. Cytoscape (www.cytoscape.org) [17] was used for network visualization.
| Evaluation of novel skin USS genes in homeostatic processes common to skin and disease processes
Probes from the upregulated and downregulated lists that showed no co-occurrences with skin in Medline abstracts were determined by natural language processing (Supporting Information; Data S3) and were imported separately as groups into Pathway Studio Software 
| Computation of USS consistency score, convergence factor and USS score
For each study examined, a consistency score (CS) was derived by assigning each of the 400 USS probes a score of +1 for significant (P < .05) and consistent directionality vs the USS, or a score of −1 for significant but reverse directionality vs the USS. Probes not significantly regulated in either direction were excluded. The convergence factor (CF) was determined by multiplying the % overlap of significantly dysregulated probes by the % consistency of directionality (ie up or down) relative to the USS. The USS score was computed using the log fold change and corresponding P-value information. For each probe, a log-P score was computed as −log10 (P-value). If, due to rounding, the P-value was 0, the minimum nonzero P-value divided by 10 was used in its place. If the log fold change indicated the effect was in the direction corresponding to healthier skin, the sign of the log-P value was reversed. The USS score was then calculated as the mean of the log-P scores across all probe sets in the signature. The 
| Clinical subjects and study designs
The clinical gene expression studies examined here were a combination of published work and our investigative studies. The study numbers and corresponding diseases, conditions or treatments described are as follows:
1. Seborrhoeic dermatitis [8] 2. Psoriasis [6] 3. Seborrhoeic dermatitis (treated) [8] 4. Acne [4] 5. Allergic contact dermatitis (96-hr positive elicited response) [18] 6. Allergic contact dermatitis (48-hr positive elicited response) [18] 7. Allergic contact dermatitis (7-hr negative elicited response) [18] 8. Mechanical removal of stratum corneum (6 hours after tape stripping)
9. Surfactant damage of healthy skin study: repeated (11 days 
| Epidermal/Dermal separation and total RNA isolation
Biopsies for studies 9-12 were processed for Laser Capture
Microdissection of the epidermis and RNA analysis and were placed into plastic cryomolds containing Optimal Cutting Temperature (Sukura Fintek, USA) compound as described. [19] In Study #8, epidermis was separated from the dermis using ammonium thiocyanate. [20] Epidermal tissues were homogenized in Trizol (Thermo Fisher, Carlsbad, CA), and RNA was extracted per manufacturer's recommendations. RNA was further purified using RNeasy spin columns (Qiagen, Hilden, Germany).
| GeneChip target synthesis and GeneChip processing
Purified total RNA was converted to cRNA GeneChip target using the Ambion (Austin, TX) MessageAmp II kit. cRNAs were hybridized to Affymetrix Human U219-96 GeneTitan arrays using the Affymetrix GeneTitan instrument and standard parameters. Image data were summarized using Affymetrix PLIER algorithm followed by statistical quality control analysis to confirm data quality.
| RE SULTS
| Discovery of the unhealthy skin signature (USS)
To identify similarities in gene expression among inflammatory skin diseases, we analysed transcriptomic profiling studies of acne, psoriasis, AD, eczema and SD. Using the consistency score algorithm, 6186 probes corresponding to 5047 genes displayed similar modes of dysregulation relative to healthy skin. These probes were grouped into four score categories: +1 to +4 for upregulated probes and −1 to −4 for downregulated probes. The top 200 most consistently regulated probes from both lists, corresponding to 152 and 160 distinct upregulated and downregulated genes, respectively, constitute the signature. We determined that several dysregulated genes showed agreement at the level of protein in AD [21] and were highly consistent with a published RNAseq study of psoriasis [22] (Supporting Information Data S7). Using natural language processing, we found that many of the 400 probe sets in the USS had no previously published associations with the skin (Supporting Information Data S3).
| GO biological processes (BP) associated with the USS
Using ToppCluster, [15, 16] we determined the GO BPs significantly and regulation of the Wnt/β-catenin pathway and actin filamentbased process were among the most significantly associated. The ratio of USS genes within a specific GO annotation ranged from approximately 3%-5% of the total number of upregulated genes and between 2% and 6% of downregulated genes. Network analysis of the associated GO BPs known to be relevant to inflammation and homeostasis demonstrates that the USS is fundamentally linked with processes that are known to be involved in tissue homeostasis.
| Pattern matching shows strong linkage of the USS to a wide variety of diseases and mild homeostatic disruptions of the skin
To determine whether the USS was representative of transcriptomic changes associated with non-dermatological diseases, we performed pattern matching against 213 unique in vitro and in vivo signatures from the GEO using CMap. The USS produces strong positive linkage scores not only to the diseases from which it was constructed, but also to a variety of other diseases as well as in vitro simulations of inflammatory cascades operative in skin disease (Table 1A) . A full table of queries of studies available at the time of this submission is provided in Supporting Information (Data S8). Pattern matching also showed that two less severe homeostatic disruptions of the skin showed positive linkage to the USS (Table 1B) . Although study #11 (surfactant challenged dry skin subjects) was not positively linked to the USS by CMap, it did link to various inflammatory skin conditions by other statistical methods (not shown). Because the same genes become dysregulated irrespective of condition and that the CF was driven mainly by the P-values associated with each USS probe vs healthy, we next used a variant of Fisher scoring to determine the relationship between P values of the dysregulation of USS probes for various conditions and the CF ( Figure 2B ).
The "USS score" shows a strong and direct correlation with the CF; both are directly related to the magnitude of homeostatic disruption, further supporting that the USS is a central feature of dysregulation developing ACD reaction) shows a higher USS score and CF, which worsens with time and displays progressively higher convergence on the USS at 48 hours and 96 hours (Studies 5 and 6). Study 9, which is mild SLS disruption in healthy subjects (baseline vs week 1), is close to Study 11, which is an even milder SLS disruption of seasonal xerosis subjects in the summer.
TA B L E 1 Connectivity Map (CMap) linkage of the USS with a variety of diseases and non-disease disruptions of epithelial homeostasis
| Cellular processes defined by upregulated USS probes and comparison to cellular processes defined by the top 200 upregulated entities from individual studies
The relationship between convergence on the USS and severity of homeostatic disruption could be interpreted as being nothing more . The top 100 most significantly enriched cellular processes identified from each study analysis were compared for the % overlap with the top 100 most significantly enriched USSdefined processes (red bar). Also shown is the P value of the most significantly enriched cellular process from each study. The actual P values (small fractional numbers) were converted to their negative log 10 values for display purposes (blue bar) >60% with the USS probe-specified processes. The most significant process specified by the disease-, condition-or treatment-related 
| Utility of the USS in discovery of potential cutaneous therapeutics
We next sought to determine whether the USS would link to the 
| D ISCUSS I ON
The present work analysed common skin diseases and discovered of a set of genes (USS) that display a common pattern of dysregulation regardless of aetiology or clinical presentation. Through pattern matching of studies in the GEO, we found that many diverse diseases show strong positive linkages to the USS, suggesting that these dysregulated genes are common to diseases that go beyond the skin.
Indeed, gene network analyses showed that the top dysregulated genes within the USS encode proteins that play roles in homeostasis in many different tissues. Theme analysis of the top USS upregulated and downregulated genes indicated associations with, unsurprisingly, innate immune processes, as well as the Wnt/β-catenin pathway and actin filament-based process. In addition to its role in embryonic development and homeostasis in self-renewing tissues, Wnt signalling participates in both pro-and anti-inflammatory crosstalk with NF-κB, [23] and dysregulation of the actin cytoskeleton has been associated with inflammation and autoimmune inflammatory cascades. [24] These findings support the well-established concept that skin has a limited repertoire of response patterns to various forms of disruption. [2] At the molecular level, this is particularly true with respect to damage and pathogen-associated molecular patterns and pattern recognition receptors in the innate immune system. [25, 26] The associations of the USS with fundamental processes governing skin physiology prompted us to ask whether less severe, non-disease disruptions of homeostasis also converge on this gene expression pattern. Studies involving mild surfactant damage of healthy skin, mechanical removal of the stratum corneum of healthy skin and mild surfactant damage of the skin of patients prone to seasonal xerosis converged on the USS, with the magnitude of convergence being directly related to the severity of the disruption.
Together, our data provide a consistent picture of the gradation of convergence on the USS, which is directly related to the severity of the condition. Moreover, our analysis of the top 400 most significantly dysregulated probe sets across all conditions showed that the significance of overrepresentation of the GO BPs separates the conditions by approximate order of severity in a manner comparable to the USS itself. This provides an unbiased assessment of the biology captured by the USS. The finding that the degree of convergence on the USS is related to the severity of the condition, and the consideration that the same genes are involved regardless of the skin condition, suggests that there is molecular continuity among disruptions of the skin and other tissues and that dysregulation of USS genes is a feature of many disruptions of homeostasis.
There are other more practical applications of gene expression profiling. CMap and other computational approaches can aid in the discovery of new therapeutics that have potential in the treatment of many diseases, especially cancers. [27, 28] We reasoned that the USS may represent a useful first-cut approach to identifying new therapeutics that could potentially be used across the skin health in various human and murine models of skin inflammation. [29] [30] [31] [32] Moreover, HDAC inhibitors have shown promising effects on alleviating pro-inflammatory responses of CD8 + T cells and Langerhans cells in contact dermatitis models as well as Th17 immune responses in psoriasis. [33] [34] [35] [36] Finally, CMap analysis of the USS also revealed several negatively linked drugs with phosphodiesterase IV (PDE-IV) inhibitory activity, including the A1 adenosine receptor antagonist sulmazole. Notably, the novel non-steroidal PDE-4 inhibitor crisaborole (EUCRISA ™ ; Pfizer) was recently approved as a topical therapeutic for AD. [37] Although the efficacies of many of these negatively 
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